Ketamine: Mechanisms and Relevance to Treatment of Depression
Top Cited Papers
Open Access
- 29 January 2024
- journal article
- review article
- Published by Annual Reviews in Annual Review of Medicine
- Vol. 75 (1) , 129-143
Abstract
Major depressive disorder (MDD) is a leading cause of suicide in the world. Monoamine-based antidepressant drugs are a primary line of treatment for this mental disorder, although the delayed response and incomplete efficacy in some patients highlight the need for improved therapeutic approaches. Over the past two decades, ketamine has shown rapid onset with sustained (up to several days) antidepressant effects in patients whose MDD has not responded to conventional antidepressant drugs. Recent preclinical studies have started to elucidate the underlying mechanisms of ketamine's antidepressant properties. Herein, we describe and compare recent clinical and preclinical findings to provide a broad perspective of the relevant mechanisms for the antidepressant action of ketamine.Keywords
This publication has 101 references indexed in Scilit:
- Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major DepressionBiological Psychiatry, 2013
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responsesNature, 2011
- The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [1H]-MRSPsychiatry Research: Neuroimaging, 2011
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA AntagonistsScience, 2010
- Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trialInternational Journal of Neuropsychopharmacology, 2010
- The Timing of Antidepressant Effects: A Comparison of Diverse Pharmacological and Somatic TreatmentsPharmaceuticals, 2010
- MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and functionProceedings of the National Academy of Sciences, 2008
- Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient GlioblastomaPLOS Medicine, 2008
- NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal NeuronsThe Journal of Neuroscience, 2007
- Miniature Neurotransmission Stabilizes Synaptic Function via Tonic Suppression of Local Dendritic Protein SynthesisCell, 2006